The protective effects of naproxen against interleukin-1β (IL-1β)- induced damage in human umbilical vein endothelial cells (HUVECs)

References

• Xu S, Kamato D, Little PJ, et al. Targeting epigenetics and non-coding RNAs in atherosclerosis: from mechanisms to therapeutics. Pharmacol Ther. 2018;196:15–43.
   PubMed Web of Science ®Google Scholar
• Karimi A, Rahmati SM, Sera T, et al. A combination of experimental and numerical methods to investigate the role of strain rate on the mechanical properties and collagen fiber orientations of the healthy and atherosclerotic human coronary arteries. Bioengineered. 2016 Sep 02;8(2):154–170.
   PubMed Web of Science ®Google Scholar
• Souilhol C, Harmsen MC, Evans PC, et al. Endothelial–mesenchymal transition in atherosclerosis. Cardiovasc Res. 2018 Mar 15;114(4):565–577.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Yang X, Bian F, et al. TNF-α promotes early atherosclerosis by increasing transcytosis of LDL across endothelial cells: crosstalk between NF-κB and PPAR-γ. J Mol Cell Cardiol. 2014 Jul 1;72:85–94.
   PubMed Web of Science ®Google Scholar
• Khan R, Rheaume E, Tardif JC, et al. Examining the role of and treatment directed at IL-1β in atherosclerosis. Curr Atheroscler Rep. 2018 Nov;20(11):1–8.
   PubMed Web of Science ®Google Scholar
• Hoseini Z, Sepahvand F, Rashidi B, et al. NLRP3 inflammasome: its regulation and involvement in atherosclerosis. J Cell Physiol. 2018 Mar;233(3):2116–2132.
   PubMed Web of Science ®Google Scholar
• Makó V, Czúcz J, Weiszhár Z, et al. Proinflammatory activation pattern of human umbilical vein endothelial cells induced by IL‐1β, TNF‐α, and LPS. Cytometry Part A. 2010 Oct;77(10):962–970.
   PubMedGoogle Scholar
• Moriya J. Critical roles of inflammation in atherosclerosis. J Cardiol. 2019 Jan 1;73(1):22–27.
   PubMed Web of Science ®Google Scholar
• Van der Heijden T, Bot I, Kuiper J, et al. The IL-12 cytokine family in cardiovascular diseases. Cytokine. 2019 Oct 1;122:154188.
   PubMed Web of Science ®Google Scholar
• Mai W, Liao Y. Targeting IL-1β in the treatment of atherosclerosis. Front Immunol. 2020;11:589654.
   PubMedGoogle Scholar
• Wang D, Patel VV, Ricciotti E, et al. Cardiomyocyte cyclooxygenase-2 influences cardiac rhythm and function. Proc Nat Acad Sci. 2009 May 5;106(18):7548–7552.
   PubMed Web of Science ®Google Scholar
• Angiolillo DJ, Weisman SM. Clinical pharmacology and cardiovascular safety of naproxen. Am J Cardiovasc Drugs. 2017 Apr;17(2):97–107.
   PubMed Web of Science ®Google Scholar
• Yin GQ, Zeng Q, Zhao HJ, et al. Effect and mechanism of calpains on pediatric lobar pneumonia. Bioengineered. 2016;8(4):374–382.
   PubMed Web of Science ®Google Scholar
• Guo JP, Chen W, Bao BB, et al. Protective effect of berberine against LPS-induced endothelial cell injury via the JNK signaling pathway and autophagic mechanisms. Bioengineered. 2021;12(1):1324–1337.
   PubMed Web of Science ®Google Scholar
• Kimura K, Hashiguchi T, Deguchi T, et al. Serum VEGF—as a prognostic factor of atherosclerosis. Atherosclerosis. 2007 Sep 1;194(1):182–188.
   PubMed Web of Science ®Google Scholar
• Tatsumi K, Mackman N. Tissue factor and atherothrombosis. J Atheroscler Thromb. 2015 Jun 16;22(6):543–549.
   PubMed Web of Science ®Google Scholar
• Crofford LJ. Use of NSAIDs in treating patients with arthritis. Arthritis Res Ther. 2013 Jul;15(S3):0–1.
   Google Scholar
• Atiquzzaman M, Kopec J, Karim ME, et al. OP0190 The role of nsaids in the association between osteoarthritis and cardiovascular diseases: a population-based cohort study. Ann Rheum Dis. 2018;77:144.
   Google Scholar
• Bindu S, Mazumder S, Bandyopadhyay U, et al. Non-steroidal anti-inflammatory drugs (NSAIDs) and organ damage: a current perspective. Biochem Pharmacol. 2020 Jul 10:114147. DOI:10.1016/j.bcp.2020.114147.
   PubMed Web of Science ®Google Scholar
• Vane J. Towards a better aspirin. Nature. 1994 Jan;367(6460):215–216.
   PubMed Web of Science ®Google Scholar
• Wongrakpanich S, Wongrakpanich A, Melhado K, et al. A comprehensive review of non-steroidal anti-inflammatory drug use in the elderly. Aging Dis. 2018 Feb;9(1):143.
   PubMed Web of Science ®Google Scholar
• Gisterå A, Hansson GK. The immunology of atherosclerosis. Nat Rev Nephrol. 2017 Jun;13(6):368.
   PubMed Web of Science ®Google Scholar
• Praticò D, Tillmann C, Zhang ZB, et al. Acceleration of atherogenesis by COX-1-dependent prostanoid formation in low density lipoprotein receptor knockout mice. Proc Nat Acad Sci. 2001 Mar 13;98(6):3358–3363.
   PubMed Web of Science ®Google Scholar
• Cipollone F, Ml F. COX-2 and atherosclerosis. J Cardiovasc Pharmacol. 2006 Jun 1;47(Supplement 1):S26–36.
   PubMedGoogle Scholar
• Todd PA, Clissold SP. Naproxen. Drugs. 1990 Jul;40(1):91–137.
   PubMedGoogle Scholar
• Duggan KC, Walters MJ, Musee J, et al. Molecular basis for cyclooxygenase inhibition by the non-steroidal anti-inflammatory drug naproxen. J Biol Chem. 2010 Nov 5;285(45):34950–34959.
   PubMed Web of Science ®Google Scholar
• Davies NM, Anderson KE. Clinical pharmacokinetics of naproxen. Clin Pharmacokinet. 1997 Apr;32(4):268–293.
   PubMed Web of Science ®Google Scholar
• Ridker PM, Libby P, MacFadyen JG, et al. Modulation of the interleukin-6 signalling pathway and incidence rates of atherosclerotic events and all-cause mortality: analyses from the canakinumab anti-inflammatory thrombosis outcomes study (CANTOS). Eur Heart J. 2018 Oct 7;39(38):3499–3507.
   PubMed Web of Science ®Google Scholar
• Ye J, Wang Y, Wang Z, et al. The expression of IL-12 family members in patients with hypertension and its association with the occurrence of carotid atherosclerosis. Mediators Inflamm. 2020 Apr 6;2020.
   Web of Science ®Google Scholar
• Branen L, Hovgaard L, Nitulescu M, et al. Inhibition of tumor necrosis factor-α reduces atherosclerosis in apolipoprotein E knockout mice. Arterioscler Thromb Vasc Biol. 2004 Nov 1;24(11):2137–2142.
   PubMed Web of Science ®Google Scholar
• Skoog T, Dichtl W, Boquist S, et al. Plasma tumour necrosis factor-α and early carotid atherosclerosis in healthy middle-aged men. Eur Heart J. 2002 Mar 1;23(5):376–383.
   PubMed Web of Science ®Google Scholar
• Sil S, Goswami AR, Dutta G, et al. Effects of naproxen on immune responses in a colchicine-induced rat model of alzheimer’s disease. Neuroimmunomodulation. 2014;21(6):304–321.
   PubMed Web of Science ®Google Scholar
• Inoue M, Itoh H, Ueda M, et al. Vascular endothelial growth factor (VEGF) expression in human coronary atherosclerotic lesions: possible pathophysiological significance of VEGF in progression of atherosclerosis. Circulation. 1998 Nov 17;98(20):2108–2116.
   PubMed Web of Science ®Google Scholar
• Marino M, Del Bo C, Tucci M, et al. Modulation of adhesion process, E-selectin and VEGF production by anthocyanins and their metabolites in an in vitro model of atherosclerosis. Nutrients. 2020 Mar;12(3):655.
   PubMed Web of Science ®Google Scholar
• Grover SP, Mackman N. Tissue factor in atherosclerosis and atherothrombosis. Atherosclerosis. 2020 Jul 3;307:80–86.
   PubMed Web of Science ®Google Scholar
• Marzolla V, Armani A, Mammi C, et al. Essential role of ICAM-1 in aldosterone-induced atherosclerosis. Int J Cardiol. 2017 Apr 1;232:233–242.
   PubMed Web of Science ®Google Scholar
• Habas K, Shang L. Alterations in intercellular adhesion molecule 1 (ICAM-1) and vascular cell adhesion molecule 1 (VCAM-1) in human endothelial cells. Tissue Cell. 2018 Oct 1;54:139–143.
   PubMed Web of Science ®Google Scholar
• Liu A, Wan A, Feng A, et al. ICAM-1 gene rs5498 polymorphism decreases the risk of coronary artery disease. Medicine (Baltimore). 2018 Oct;97(40):e12523.
   Web of Science ®Google Scholar
• Seok SM, Park DH, Kim YC, et al. COX-2 is associated with cadmium-induced ICAM-1 expression in cerebrovascular endothelial cells. Toxicol Lett. 2006 Sep 10;165(3):212–220.
   PubMed Web of Science ®Google Scholar
• Wang H, Yang G, Zhang Q, et al. Apremilast ameliorates ox-LDL-induced endothelial dysfunction mediated by KLF6. Aging (Albany NY). 2020 Oct 15;12(19):19012.
   PubMedGoogle Scholar
• Mahabaleshwar GH, Ng HP, Kim G, et al. Klf6 promotes macrophage pro-inflammatory activation and atherogenesis. Arterioscler Thromb Vasc Biol. 2020 May;40(Suppl_1):A311.
   Google Scholar